Lilly is seeking a head of Analytical Development within its Cell and Gene Therapy (CGT) Development organization. This high-visibility role will define the global enterprise strategy for maturation, innovation, site bridging, and regulatory alignment of the analytical platform for clinical CGT programs through BLA/MAA. Current technologies include AAV, mRNA/LNP, and LVV products at various stages of clinical development. The role manages the department responsible for development, registration, commercialization, and analytical control strategies for CGT projects. Work includes analytical method development, qualification and transfer, process-development support, non-GMP stability studies, physical and chemical characterization, and preparation of relevant regulatory submission sections. The position leads a team of approximately 75 FTEs and oversees resourcing, budgets, capital expenditures, headcount, project progress, compliance, laboratory safety, and staff development. The role is based in Boston, Massachusetts.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior